European Commission Approves Novavax's Adapted COVID-19 Vaccine for Winter Season
The European Commission has granted approval for the Nuvaxovid XBB.1.5-adapted COVID-19 vaccine, a groundbreaking step in the fight against the ever-evolving pandemic
American molecular biologists have created and successfully tested experimental nanoparticles against all strains of influenza A virus that cause the most serious epidemics. The news is published in an article in Nature Communications magazine.
"Our vaccine consists of fragments of different virus proteins that are almost unchanged in the course of its evolution. For this reason, the immune response affects all strains of influenza, which is uncharacteristic for the usual seasonal vaccines, which are directed against that part of the virus that is most rapidly changing. Our vaccine has no such disadvantage, and in the future when clinical trials are completed, it will protect a person from flu for a long time, "said Ley Dunn, of the University of Georgia, in Atlanta.
Every year, flu epidemics takes thousands of lives away. Fighting the disease is complicated by the fact that this virus has three varieties - A, B and C. For this reason, it is difficult to predict which species will get the most prevalence in this or next year. In addition, the vaccine allows immunity to only one or several strains.
The most dangerous viruses belong to type A. Its varieties are divided into groups A1 and A2. To the first group is the swine virus, and the second to the bird flu.
Lew Dunn and his colleagues have made the first serious step towards creating a universal vaccine that protects us from all type A viruses. For this purpose, they have created nanoparticles consisting of several layers of fat and fragments of hemagglutinin, the protein armor of the virus that plays a key a role in its attachment to pulmonary cells.
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
New data from the World Health Organization (WHO) underscores concerns over the global surge in antibiotic usage during the Covid-19 pandemic, potentially exacerbating the silent threat of antimicrobial resistance.
The Ministry of Health in Bulgaria has announced a significant initiative to provide free whooping cough vaccines to all pregnant women between 27 to 36 weeks of gestation
A recent UN report on the health behaviors of school-age children has unveiled concerning trends regarding alcohol and cigarette consumption among Bulgarian students, sparking widespread concern
In a recent announcement that's bound to catch attention, Bulgaria's Chief State Health Inspector, Assoc. Angel Kunchev, declared that the country will not be declaring an emergency epidemic situation due to the spread of whooping cough
In a recent interview with BTA, Associate Professor Angel Kunchev, the chief state health inspector, addressed the potential declaration of an epidemic of whooping cough and outlined the measures that would be taken in response
As Bulgaria grapples with a surge in whooping cough cases, Public Health experts offer insights into the situation, assuring the public about the severity of symptoms and emphasizing the importance of vaccination
UN Happiness Report: Bulgaria's Astonishing Leap in Rankings
Bulgaria: 3 Regions With Lowest Life Expectancy - EU Report 2022